| Nov 13 |
Pulmatrix and Cullgen announce proposed merger
|
| Nov 13 |
Pulmatrix and Cullgen Announce Proposed Merger
|
| Nov 10 |
Pulmatrix Third Quarter 2024 Earnings: US$0.71 loss per share (vs US$1.03 loss in 3Q 2023)
|
| Nov 8 |
Pulmatrix GAAP EPS of -$0.71, revenue of $0.37M
|
| Nov 8 |
Pulmatrix Announces Third Quarter 2024 Financial Results and Provides Corporate Update
|
| Aug 15 |
Pulmatrix Second Quarter 2024 Earnings: US$1.59 loss per share (vs US$1.05 loss in 2Q 2023)
|
| Aug 14 |
Pulmatrix GAAP EPS of -$1.59, revenue of $1.6M
|
| May 29 |
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation
|
| May 17 |
Pulmatrix files for $95M mixed shelf
|
